title: [Use of psychotropic medication among individuals with mental retardation].
abstract: BACKGROUND
  Individuals who have mental retardation and live by themselves have little knowledge of psychotropic medication. The aim of this study is to examine the use of psychotropic medication among individuals with mental retardation, 10-20 years after they moved from institutionalised to open care.
  
  
  METHODS
  116 individuals with mental retardation, who had moved from one specific institution to open care (in their own homes) in the period 1984-94, were included in the study. Data were collected from medical records, and from interviews with a caregiver.
  
  
  RESULTS
  50 (43%) individuals used psychotropic drugs at the time of recording. It was common to use combinations of psychotropic drugs; 37 used antipsychotics, nine used antidepressants and 14 used anxiolytics. Information on the degree of retardation was not available for all individuals; but 20 of the 28 who used antipsychotics had serious mental retardation, while eight had a mild or moderate degree of mental retardation (p < 0.001). No statistically significant association was found between degree of retardation and use of antidepressants and anxiolytics. Only 14 (27%) of those who used psychotropic drugs had a psychiatric diagnosis. The drugs were usually prescribed by a regular general practitioner.
  
  
  CONCLUSIONS
  Individuals with mental retardation use psychotropic medication extensively. Caregivers' insufficient knowledge on how to apply non-pharmacological intervention may be an explanation for the extensive use of psychotropic drugs in treatment of challenging behaviour.
authors.affiliation: Seksjon for voksenhabilitering, Psykiatrisk klinikk, Sykehuset Telemark, Eidsbygda, 3825 Lunde, Norway. gro.baasland@sthf.no
authors.forename: Gro
authors.initials: G
authors.lastname: Baasland
authors.forename: Knut
authors.initials: K
authors.lastname: Engedal
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D004363:Drug Utilization / Q000706:statistics & numerical data; D006801:Humans; D008607:Intellectual Disability / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D019338:Polypharmacy; D011619:Psychotropic Drugs / Q000008:administration & dosage* / Q000009:adverse effects; D011795:Surveys and Questionnaires
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D011619:Psychotropic Drugs